HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel combined conjugate vaccine: enhanced immunogenicity of bFGF with CRM197 as a carrier protein.

Abstract
Tumor growth is partly dependent on tumor-associated angiogenesis, which is regulated by angiogenic growth factors. As the first angiogenic growth factor to be identified, basic fibroblast growth factor (bFGF) plays a major role in angiogensis and tumor growth and has been an effective target for anti-tumor therapy. However, due to its low immunogenicity, injection with bFGF alone cannot stimulate the body to produce a strong immune response. In this study, we investigated the role of CF (containing bFGF and CRM197) assisted by CpG and alum in enhancing antigen-specific immune response and suppressing the growth of murine colon carcinoma. The results revealed that compared to bFGF, CF could not stimulate NIH-3T3 fibroblast proliferation even at a concentration of 10 µg/ml in vitro. In vivo, the CF-CpG-alum produced a stronger antigen-specific immune response and inhibited tumor growth. The anti-tumor activity was associated with generating antigen-specific antibody, suppressing angiogenesis, promoting the apoptosis of tumor cells and inducing the mixed Th1 and Th2 responses. This indicates that CRM197 may be an innovative intramolecular adjuvant and provides a rational preservation for mouse CT26 colon carcinoma.
AuthorsHai-Long Zhang, Chuang Yuan, Dong-Mei Zhang, Hua-Shan Shi, Meng Li, Zi-Chao Luo, Yang Wan, Lian Lu, Shun-Tao Luo, Li Yang
JournalMolecular medicine reports (Mol Med Rep) 2011 Sep-Oct Vol. 4 Issue 5 Pg. 857-63 ISSN: 1791-3004 [Electronic] Greece
PMID21720718 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alum Compounds
  • Bacterial Proteins
  • CPG-oligonucleotide
  • Cancer Vaccines
  • Carrier Proteins
  • Immunoglobulin G
  • Oligodeoxyribonucleotides
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Recombinant Fusion Proteins
  • Vaccines, Conjugate
  • CRM197 (non-toxic variant of diphtheria toxin)
  • Fibroblast Growth Factor 2
  • aluminum sulfate
Topics
  • Alum Compounds
  • Animals
  • Apoptosis
  • Bacterial Proteins (immunology, toxicity)
  • Cancer Vaccines (immunology, toxicity)
  • Carrier Proteins (immunology)
  • Female
  • Fibroblast Growth Factor 2 (immunology)
  • Genetic Vectors (genetics)
  • Humans
  • Immunity (immunology)
  • Immunoglobulin G (blood, classification, immunology)
  • In Situ Nick-End Labeling
  • Mice
  • Mice, Inbred BALB C
  • NIH 3T3 Cells
  • Neoplasms (blood supply, immunology)
  • Neovascularization, Pathologic (pathology)
  • Oligodeoxyribonucleotides (immunology)
  • Platelet Endothelial Cell Adhesion Molecule-1 (metabolism)
  • Recombinant Fusion Proteins (isolation & purification)
  • Treatment Outcome
  • Vaccines, Conjugate (immunology, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: